CUSIP 76243J105 · who reports it, how much, and how much it matters to them
38 of the 720 hedge fund managers we track reported shares of Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) on Form 13F for 30 June 2026. Between them they reported USD 2.5bn. The largest position belongs to Ra Capital Management, at USD 740m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management1 fund on PPLI.com | USD 740m | 6.4% |
| 2 | Baker Bros. Advisors2 funds on PPLI.com | USD 622m | 3.1% |
| 3 | Perceptive Advisors6 funds on PPLI.com | USD 287m | 4.3% |
| 4 | Polar Capital LLP26 funds on PPLI.com | USD 185m | 0.4% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 140m | 0.0% |
| 6 | Rock Springs Capital Management2 funds on PPLI.com | USD 77m | 3.8% |
| 7 | Squarepoint Ops7 funds on PPLI.com | USD 47m | 0.1% |
| 8 | POINT72 Asset Management17 funds on PPLI.com | USD 46m | 0.1% |
| 9 | Sofinnova Investments1 fund on PPLI.com | USD 45m | 2.3% |
| 10 | Adage Capital Management1 fund on PPLI.com | USD 44m | 0.1% |
| 11 | Braidwell12 funds on PPLI.com | USD 42m | 1.6% |
| 12 | Artisan Partners1 fund on PPLI.com | USD 39m | 0.1% |
| 13 | Orbimed Advisors1 fund on PPLI.com | USD 36m | 0.7% |
| 14 | Millennium Management6 funds on PPLI.com | USD 35m | 0.0% |
| 15 | Logos Global Management1 fund on PPLI.com | USD 14m | 0.6% |
| 16 | PFM Health Sciences3 funds on PPLI.com | USD 11m | 1.0% |
| 17 | Sphera Funds Management1 fund on PPLI.com | USD 8.9m | 1.2% |
| 18 | Atom Investors1 fund on PPLI.com | USD 8.2m | 0.7% |
| 19 | Capital Fund Management S.A.12 funds on PPLI.com | USD 7.6m | 0.0% |
| 20 | Renaissance Technologies13 funds on PPLI.com | USD 7.6m | 0.0% |
| 21 | Exoduspoint Capital Management7 funds on PPLI.com | USD 6.8m | 0.0% |
| 22 | Cinctive Capital Management5 funds on PPLI.com | USD 4.7m | 0.2% |
| 23 | Zweig-Dimenna Associates3 funds on PPLI.com | USD 4.7m | 0.4% |
| 24 | Exome Asset Management2 funds on PPLI.com | USD 3.6m | 2.2% |
| 25 | D. E. Shaw & Co.15 funds on PPLI.com | USD 3.3m | 0.0% |
| 26 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 3.2m | 0.0% |
| 27 | Aquatic Capital Management3 funds on PPLI.com | USD 2.2m | 0.1% |
| 28 | Tudor Investment Corporation10 funds on PPLI.com | USD 1.5m | 0.0% |
| 29 | HighVista Strategies27 funds on PPLI.com | USD 1.5m | 0.3% |
| 30 | Marshall Wace LLP84 funds on PPLI.com | USD 908,000 | 0.0% |
| 31 | Walleye Capital8 funds on PPLI.com | USD 666,000 | 0.0% |
| 32 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 556,000 | 0.1% |
| 33 | Two Sigma Investments35 funds on PPLI.com | USD 511,000 | 0.0% |
| 34 | Magnetar Financial93 funds on PPLI.com | USD 434,000 | 0.0% |
| 35 | Capstone Investment Advisors25 funds on PPLI.com | USD 334,000 | 0.0% |
| 36 | CIBC Asset Management69 funds on PPLI.com | USD 234,000 | 0.0% |
| 37 | Bayforest Capital1 fund on PPLI.com | USD 56,736 | 0.1% |
| 38 | The Quarry1 fund on PPLI.com | USD 3,220 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management | USD 740m | 6.4% |
| 2 | Perceptive Advisors | USD 287m | 4.3% |
| 3 | Rock Springs Capital Management | USD 77m | 3.8% |
| 4 | Baker Bros. Advisors | USD 622m | 3.1% |
| 5 | Sofinnova Investments | USD 45m | 2.3% |
| 6 | Exome Asset Management | USD 3.6m | 2.2% |
| 7 | Braidwell | USD 42m | 1.6% |
| 8 | Sphera Funds Management | USD 8.9m | 1.2% |
| 9 | PFM Health Sciences | USD 11m | 1.0% |
| 10 | Atom Investors | USD 8.2m | 0.7% |
Rhythm Pharmaceuticals, Inc. trades under the symbol RYTM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 76243J105.
38 of the 720 hedge fund managers PPLI.com tracks reported Rhythm Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 740m), Baker Bros. Advisors (USD 622m), Perceptive Advisors (USD 287m), Polar Capital LLP (USD 185m) and Citadel Advisors (USD 140m).
38 managers in our coverage reported it, and between them they run 571 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Ra Capital Management, where the position was 6.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Rhythm Pharmaceuticals, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.